Coverage of Mass Drug Administration and Outcomes for Schistosomiasis and Soil Transmitted Helminths, Uganda, 2013–2023

Author:

Namara Benigna G.1,Kwesiga Benon1,Migisha Richard1,Bulage Lilian1,Tinkitina Benjamin2,Ario Alex Riolexus3,Mubangizi Alfred2

Affiliation:

1. Uganda Public Health Fellowship Program, Uganda National Institute of Public Health

2. Vector Borne and Neglected Topical Diseases Division, Ministry of Health

3. Uganda National Institute of Public Health

Abstract

Abstract

Background Uganda has a high burden of Neglected Tropical Diseases (NTDs), particularly affecting the rural populations. Some NTDs are targeted for control/elimination using preventive chemotherapy administered annually or bi-annually to populations at risk through mass drug administration (MDA). Schistosomiasis and soil transmitted helminths (STHs) are among these. MDA for Schistosomiasis is given only to school-age children (SAC) and adults while that for STHs is given only to SAC and pre-school-age children (preSAC). The MDA coverage target for both these NTDs is 75%. Decline in size of population at risk (PAR) and number of cases are indicators of effective control/progress towards elimination. We describe the trends in coverage of MDA and outcomes for schistosomiasis and STHs. Methods We reviewed available data on MDA coverage, size of population at risk and disease occurrence (case counts) for schistosomiasis and STHs from 2013 to 2023. We analysed the trends using the Mann Kendal test. Results From 2014–2022, there was an apparent increase in MDA coverage for schistosomiasis for both SAC (from 21–82%, p = 0.5) and adults (from 34–36%, p = 0.1) but both trends were not significant. Similarly, for STHs, MDA coverage increased for both SAC (from 63–114%, p = 0.09) and preSAC (from 65–76%, p = 1.0), but these trends were not significant. The PAR for schistosomiasis increased by 25% for SAC (2014: 4,777,189 vs 2022: 5,979,311, p = 0.002) and by 60% for adults (2014: 4,436,444 vs 2022: 7,091,933, p = 0.03). For STHs, PAR increased by 19% for both SAC (2014:11,287,385 vs 2022:13,397,219, p = 0.03) and preSAC (2014: 5,279,025 vs 2022: 6,299,355, p = 0.047). From 2013–2023, there was a 62% reduction in reported cases of Schistosomiasis (2013: 6518 vs 2023: 2501, p = 0.7) and a 52% reduction in reported cases of STHs (2013: 2,457,021 vs 2023:1,176,463, p = 0.5) but both trends were not significant. Conclusions Current efforts to control Schistosomiasis and STHs are ineffectual. Efforts to improve and maintain MDA coverage for both NTDs to the target of 75% are crucial, while the rise in PAR and unabating case counts necessitates targeted interventions including improved sanitation, health education and vaccine development.

Publisher

Springer Science and Business Media LLC

Reference20 articles.

1. Neglected tropical diseases in Uganda: the prospect and challenge of integrated control;Kolaczinski JH;Trends Parasitol,2007

2. Neglected tropical diseases -- GLOBAL [Internet]. [cited 2024 Jan 30]. https://www.who.int/health-topics/neglected-tropical-diseases

3. The London Declaration on NTDs [Internet]. Global Health Progress. [cited 2024 Jan 30]. https://globalhealthprogress.org/collaboration/the-london-declaration-on-ntds-2/

4. afr-rc63-. r6-regional-strategy-on-neglected-tropical-diseases.pdf [Internet]. [cited 2024 Jan 30]. https://www.afro.who.int/sites/default/files/sessions/resolutions/afr-rc63-r6-regional-strategy-on-neglected-tropical-diseases.pdf

5. Uniting to Combat. NTDs [Internet]. [cited 2024 Jan 30]. Addis Ababa Neglected Tropical Diseases Commitment. https://unitingtocombatntds.org/en/neglected-tropical-diseases/resources/addis-ababa-neglected-tropical-diseases-commitment/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3